Although the difference did not reach statistical significance, the GGO-A group had lower 5-year recurrence-free survival (RFS, 98.2% vs. 100%, P=0.13, Figure 2E ) and disease-free survival (DFS, 96.4% vs. 98.8%, P=0.08, Figure 2F ) rates compared with the GGO-nA group, suggesting a trend toward worse outcomes for GGO-A.
← all excerpts
Pulmonary ground-glass opacity associated with cystic airspace: clinicopathological features and aggressiveness.
1
0.1300
0.1300